Adicet BioACET
13F holders, Q4 2025 (December 31)1holders −53
0new positions
53sold out
$8.42avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Adicet Bio Inc. (ACET) in their 13F filings, down 53 from Q3 2025. 0 opened new positions and 53 sold out. The largest holder was Regeneron Pharmaceuticals, Inc. ($510K).
- Company
- Adicet Bio Inc.
- CUSIP
- 007002108
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 53 | $40.9M |
All 13F filers, Q3 2025 → Q4 2025: 51,341,490 shares sold, net −51,341,490 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Regeneron Pharmaceuticals, Inc. | 1.51% | Reduce -93.8% | 60,511 | $510K |
"% of holder's portfolio" is ACET's weight in each manager's 13F, not the share of Adicet Bio Inc. the manager owns.